{"filings":[{"id":746963,"accession_number":"0001193125-26-248342","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2026-05-29T20:15:56+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Xylem issues $1B in senior notes: $500M at 5.200% due 2033, $500M at 5.450% due 2036","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$500M 5.200% Senior Notes due June 1, 2033; $500M 5.450% Senior Blue Notes due June 1, 2036.","Proceeds from 2033 notes to repay or redeem $500M 3.250% Senior Notes due Nov 2026.","Net proceeds from 2036 Blue Notes allocated to eligible blue projects; pending allocation held in treasury.","Notes are senior unsecured, rank equally with existing unsecured obligations; change-of-control repurchase at 101%.","Interest payable semi-annually on June 1 and Dec 1, starting Dec 1, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":499637,"accession_number":"0001524472-26-000091","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2026-05-18T20:19:58+00:00","items":["5.07"],"status":"ready","headline":"Xylem shareholders elect nine directors, ratify auditor, approve advisory compensation and ESPP","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected with at least 84.6% of votes cast; Jerome Peribere received 20.75M against.","Ratification of Deloitte & Touche as independent auditor for 2026: 205.4M for, 6.2M against.","Advisory vote on named executive compensation passed: 176.6M for, 24.4M against.","2026 Employee Stock Purchase Plan approved: 200.9M for, 313.9K against.","Turnout at 88.12% of outstanding shares (212.2M of 240.8M)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93407,"accession_number":"0001524472-26-000065","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem Q1 adjusted EPS $1.12 (+9%), revenue $2.1B (+3%); FY guidance raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 orders $2.2B (+3% reported, flat organic); revenue $2.1B (+3% reported).","GAAP EPS $0.79 (+14%); adjusted EPS $1.12 (+9%); adjusted EBITDA margin 20.6% (+20 bps).","FY2026 revenue forecast raised to ~$9.2-9.3B (reported growth 2-3%, prior 1-3%).","Adjusted EPS guidance maintained at $5.35-$5.60; adjusted EBITDA margin 22.9-23.3% expected.","Free cash flow margin still expected ~10.2-11.0% for full year 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":0.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":2125000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104997,"accession_number":"0001524472-26-000014","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Xylem Board authorizes $1.5B share repurchase program with no expiration","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New share repurchase program authorizes up to $1.5 billion in common stock purchases.","Program has no expiration date and may be suspended at any time.","Repurchases may be made through open market purchases or other methods.","Program does not obligate the company to acquire any specific amount of stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104996,"accession_number":"0001524472-26-000008","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem Q4 adjusted EPS $1.42 (+20% YoY), full-year revenue $9.0B record; dividend raised 8%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $2.4B (+6% reported, +4% organic); orders $2.4B (+9%, +7% organic).","GAAP EPS $1.37; adjusted EPS $1.42, up 20% YoY on productivity and price.","Full-year revenue $9.0B (+6% reported, +5% organic); adjusted EPS $5.08 (+19%).","Dividend increased 8% to $0.43/share; payable March 24, 2026 to Feb 24 record date.","2026 guidance: revenue $9.1-9.2B (2-4% organic growth); adjusted EPS $5.35-5.60."],"consensus_eps_estimate":null,"consensus_eps_actual":3.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":9035000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121238,"accession_number":"0001524472-25-000043","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem Q3 2025: revenue up 8% to $2.3B; adj. EPS $1.37, +23%; raises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2.3B, +8% reported (+7% organic); net income $227M ($0.93 EPS).","Adjusted EPS $1.37, +23% YoY; adjusted EBITDA margin 23.2% (+200 bps).","Full-year 2025 guidance raised: revenue ~$9.0B (+5-6%), adj. EPS $5.03-$5.08 (from $4.70-$4.85).","Growth across all segments; double-digit gains in Measurement & Control and Water Solutions & Services.","CEO cites strong execution, resilient demand; free cash flow margin reaffirmed at 9-10%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":6638000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137888,"accession_number":"0001524472-25-000035","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem Q2 revenue $2.3B (+6% organic); EPS $0.93; adj. EPS $1.26; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2.3B, up 6% reported and organic; net income $226M ($0.93/share), up 16%.","Adjusted EPS $1.26, up 16%; adjusted EBITDA margin 21.8% (record), +100 bps YoY.","Raises FY 2025 revenue guidance to ~$8.9-9.0B (+4-5% reported vs prior 1-2%).","FY adjusted EPS guidance raised to $4.70-4.85 from prior $4.50-4.70.","CEO cites strong execution, resilient demand, and operating model transformation."],"consensus_eps_estimate":null,"consensus_eps_actual":1.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":4370000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155272,"accession_number":"0001524472-25-000025","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Xylem shareholders elect all nine director nominees, ratify Deloitte, approve say-on-pay; shareholder proposal fails","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["All nine director nominees elected: Earl R. Ellis, Robert F. Friel, Lisa Glatch, Victoria D. Harker, Mark D. Morelli, Jerome A. Peribere, Matthew F. Pine, Lila Tretikov, Uday Yadav.","Ratification of Deloitte & Touche LLP as independent auditor for 2025 approved with 208,116,815 votes for.","Advisory vote on named executive compensation approved with 178,806,646 votes for.","Shareholder proposal to improve special shareholder meeting process defeated with 94,569,014 votes in favor, short of majority of outstanding shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155271,"accession_number":"0001524472-25-000019","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem Q1 revenue $2.1B, adj EPS $1.03, beats expectations; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2.1B, up 2% reported and 3% organic; book-to-bill ratio above 1.0.","GAAP EPS $0.69 (+10% YoY); adjusted EPS $1.03 (+14% YoY).","Net income $169M; adjusted EBITDA margin 20.4%, up 120 bps YoY.","Reaffirmed FY2025 adj EPS guidance $4.50-$4.70 and organic revenue growth ~3-4%.","CEO cites strong operating discipline and margin expansion, offsetting tariff impacts."],"consensus_eps_estimate":null,"consensus_eps_actual":0.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":2069000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173788,"accession_number":"0001524472-25-000010","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem beats Q4 guidance; revenue $2.3B, adj. EPS $1.18; raises dividend 11%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $2.3B, up 7% organic; orders $2.2B, up 7%; GAAP EPS $1.34 (+22%), adjusted EPS $1.18 (+19%).","Full-year 2024 revenue $8.6B (+6% organic); GAAP EPS $3.65 (+31%), adjusted EPS $4.27 (+13%).","Board declared Q1 dividend $0.40/share, an 11% increase; payable Mar 19, 2025 to holders of record Feb 18.","FY2025 guidance: revenue ~$8.6-8.7B (organic +3-4%), adjusted EPS $4.50-4.70, adj. EBITDA margin 21.3-21.8%.","Q4 adjusted EBITDA margin 21.0%, +140 bps YoY; full-year free cash flow margin guided 9-10% for 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":3.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":8562000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173787,"accession_number":"0001524472-25-000006","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["2.02","2.05"],"status":"ready","headline":"Xylem confirms FY2024 results in-line/above guidance; announces restructuring with $95-115M charges","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On Jan 28, 2025, management committed to a restructuring plan with workforce reductions across all businesses.","Pre-tax charges estimated at $95M-$115M primarily in 2025, including ~$19M in Q4 2024.","Company confirms full-year 2024 financial results will be largely in line with or above prior guidance (Oct 31, 2024).","Majority of workforce reductions expected by end of 2025, some into 2026.","Charges consist of severance, termination benefits, and associated costs, paid in cash."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173786,"accession_number":"0001524472-25-000003","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2025-01-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Xylem director Jeanne Beliveau-Dunn to not seek re-election at 2025 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeanne Beliveau-Dunn informed Board on Jan 10, 2025 of her decision not to stand for re-election.","Departure is not due to any disagreement with the Company or Board regarding operations, policies, or practices.","She will continue serving until the 2025 annual meeting; Board size will reduce to nine members.","No replacement director has been announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190772,"accession_number":"0001524472-24-000043","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem Q3 revenue $2.1B, adjusted EPS $1.11 (+12% YoY); narrows FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2.1B, up 1% reported and organic; orders up 8%.","GAAP EPS $0.89 (+41% YoY); adjusted EPS $1.11 (+12% YoY).","Adjusted EBITDA margin 21.2%, up 140 bps YoY; net income margin 10.3%.","Full-year revenue guidance $8.5B (~+15% reported, +5% organic).","Narrowed FY adjusted EPS guidance to $4.22-$4.24 from $4.18-$4.28."],"consensus_eps_estimate":null,"consensus_eps_actual":2.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":6306000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190771,"accession_number":"0001524472-24-000040","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2024-10-15T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Xylem appoints Meredith Emmerich as Applied Water President; Cerwinka steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Franz Cerwinka steps down as SVP & President, Applied Water effective Oct 21; advisor until March 31, 2025.","Meredith Emmerich named new SVP & President, Applied Water effective Oct 21, reporting to CEO Matthew Pine.","Emmerich joins from Carrier (NYSE: CARR), where she led Global Enterprise Solutions; 20+ years experience.","Cerwinka receives $570,630 annual base salary during transition; equity awards continue vesting through termination.","Emmerich will lead Applied Water segment, offering water management for industrial and commercial buildings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207242,"accession_number":"0001524472-24-000031","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2024-07-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem Q2 revenue $2.2B (+26% reported, +9% organic); EPS $0.80, adj EPS $1.09; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $194M ($0.80 EPS), up 78%; adjusted EPS $1.09, up 11%.","Orders grew 12% reported; organic revenue declined 1% on tough comp.","Adjusted EBITDA margin 20.8%, up 170 bps YoY.","FY 2024 revenue guidance raised to $8.55B (+16% reported, +5-6% organic).","FY adj EPS guidance raised to $4.18-$4.28; free cash flow conversion at least 120%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":4202000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224622,"accession_number":"0001524472-24-000019","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Xylem shareholders elect all 10 directors, approve say-on-pay and auditor at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 10 director nominees elected, with support ranging from 88.4% to 95.0% of votes cast (excluding broker non-votes).","Ratification of Deloitte & Touche as auditor for 2024: 206,099,678 for, 8,611,443 against, 699,803 abstentions.","Advisory say-on-pay approved: 169,326,139 for, 35,430,043 against, 339,675 abstentions (excluding ~10.3M broker non-votes).","Shareholders voted for a 1-year frequency for future advisory votes on executive compensation (201,496,786 votes for 1 year).","Meeting had 215,410,924 shares represented, or 88.86% of outstanding common stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224621,"accession_number":"0001524472-24-000013","cik":1524472,"company_name":"Xylem Inc.","ticker":"XYL","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Xylem beats Q1 estimates, raises FY revenue and adjusted EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue of $2.0B (+40% reported, +7% organic); orders $2.2B (+43% reported, +3% organic).","GAAP EPS $0.63 (+17%); adjusted EPS $0.90 (+14%); net income $153M; adjusted net income $219M.","FY 2024 revenue guidance raised to ~$8.5B (+15-16% reported, +4-6% organic).","Adjusted EPS guidance raised to $4.10-$4.25 from $4.00-$4.20; adjusted EBITDA margin now ~20%.","Record Q1 margins driven by productivity, favorable mix; Evoqua integration on track."],"consensus_eps_estimate":null,"consensus_eps_actual":0.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":2033000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":25276330000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}